IMMUNOSARC: a collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I/II trial of sunitinib and nivolumab in advanced soft tissue and bone sarcoma: Results from the phase II part, bone sarcoma cohort.

Authors

null

Emanuela Palmerini

IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy

Emanuela Palmerini , Antonio Lopez-Pousa , Giovanni Grignani , Andres Redondo , Nadia Hindi , Silvia Stacchiotti , Ana Sebio , Jose A. Lopez-Martin , Claudia Maria Valverde Morales , Javier Martinez-Trufero , Antonio Gutierrez , Enrique de Alava , Lorenzo D'Ambrosio , Paola Collini , Piero Picci , Paolo Giovanni Casali , Javier Martin Broto

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Bone Tumors

Clinical Trial Registration Number

NCT03277924

Citation

J Clin Oncol 38: 2020 (suppl; abstr 11522)

DOI

10.1200/JCO.2020.38.15_suppl.11522

Abstract #

11522

Poster Bd #

410

Abstract Disclosures

Similar Posters

First Author: Sant P. Chawla

Poster

2023 ASCO Annual Meeting

A phase II study of tinostamustine in patients (pts) with advanced solid tumours.

A phase II study of tinostamustine in patients (pts) with advanced solid tumours.

First Author: Anna Tinker

First Author: Sonam Puri